RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
基本信息
- 批准号:3128841
- 负责人:
- 金额:$ 15.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-04-01 至 1989-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Enveloped RNA viruses are the etiological agents for many human
diseases-ranging from yellow fever, the first human disease
attributable to a virus (1902), to acquired immune deficiency
syndrome, caused by the retrovirus HTLVIII/LAV (1984). Although
these two viruses, as well as other enveloped RNA viruses, differ
importantly in their genomic structure, composition and
mechanisms for gene expression, they have some activities in
common in their replication cycle and all synthesize virus-specific
transmembranal glycoproteins that interact with virus
nucleoprotein structures during virus assembly. Experiments in
this proposal are focused on this common activity but employ a
simple "model" enveloped RNA virus-cell system, Sindbis virus
replication in tissue culture cells. These projects constitute an
ongoing research program whose goal is the elucidation of critical
biochemical events in glycoprotein processing and assembly of
enveloped RNA viruses. The work proposed here will utilize
recombinant DNA technology to obtain site-specific mutations in
a specific region of this virus' glycoprotein to determine what
factors are required to achieve the highly selective interaction
between the transmembranal virus "spike" proteins and
nucleocapsid of the virus. Systems to measure binding between
nucleocapsids and glycoproteins will also be sought. Of particular
interest is what role fatty acylation, a modification present in
many virus and cell glycoproteins, may play in virus assembly. In
vitro mutagenesis will be used further to analyze a small region in
the Sindbis genome required for processing and insertion of
glycoprotein into the cell's membrane. Our ability to detect
effects of directed glycoprotein changes on virus assembly are
now feasible because a cDNA capable of transcription into an
infectious RNA has been developed.
包裹的RNA病毒是许多人类的病因
疾病来自黄热病,第一种人类疾病
归因于病毒(1902),可获得免疫缺陷
综合征,由逆转录病毒HTLVIII/LAV(1984)引起。 虽然
这两种病毒以及其他包膜的RNA病毒都不同
重要的是它们的基因组结构,组成和
基因表达的机制,它们有一些活动
在其复制周期中常见和所有合成病毒特异性
与病毒相互作用的跨膜糖蛋白
病毒组装过程中的核蛋白结构。 实验
该提案的重点是这项共同活动,但采用了
简单的“模型”包裹的RNA病毒细胞系统,sindbis病毒
在组织培养细胞中复制。 这些项目构成
正在进行的研究计划,其目标是阐明关键
糖蛋白加工和组装中的生化事件
包裹的RNA病毒。 这里提出的工作将利用
重组DNA技术以获得位点特异性突变
该病毒糖蛋白的特定区域,以确定什么
需要因素才能实现高度选择性的互动
在跨膜病毒“尖峰”蛋白和
病毒的核包囊。 测量结合之间的系统
还将寻求核蛋白质和糖蛋白。 特别
兴趣是哪种角色脂肪酰化,这是一种修改
许多病毒和细胞糖蛋白可能会在病毒组装中发挥作用。 在
体外诱变将进一步分析
加工和插入所需的信德比斯基因组
糖蛋白进入细胞的膜。 我们检测的能力
定向糖蛋白变化对病毒组装的影响是
现在是可行的,因为能够转录到一个
已经开发了感染性RNA。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
MILTON J SCHLESING...的其他基金
PEPTIDE-BASED INHIBITORS OF ENVELOPED VIRUS ASSEMBLY
基于肽的包膜病毒组装抑制剂
- 批准号:35479013547901
- 财政年份:1991
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
PEPTIDE-BASED INHIBITORS OF ENVELOPED VIRUS ASSEMBLY
基于肽的包膜病毒组装抑制剂
- 批准号:20668402066840
- 财政年份:1991
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
PEPTIDE-BASED INHIBITORS OF ENVELOPED VIRUS ASSEMBLY
基于肽的包膜病毒组装抑制剂
- 批准号:35479003547900
- 财政年份:1991
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
PEPTIDE-BASED INHIBITORS OF ENVELOPED VIRUS ASSEMBLY
基于肽的包膜病毒组装抑制剂
- 批准号:35479023547902
- 财政年份:1991
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
UBIQUITIN AND INTRACELLULAR PROTEIN DEGRADATION
泛素和细胞内蛋白质降解
- 批准号:34350383435038
- 财政年份:1989
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
- 批准号:31288423128842
- 财政年份:1982
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
- 批准号:31288433128843
- 财政年份:1982
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
- 批准号:31288393128839
- 财政年份:1982
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
- 批准号:31288383128838
- 财政年份:1982
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
RNA-ENVELOPE VIRUS FORMATION IN ANIMAL CELLS
动物细胞中 RNA 包膜病毒的形成
- 批准号:31288373128837
- 财政年份:1982
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
相似国自然基金
NudC在细胞初级纤毛生长调节中的作用及分子机制研究
- 批准号:31471259
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
溶血磷脂酸在心梗后心肌重塑中作用及受体调节信号研究
- 批准号:30170374
- 批准年份:2001
- 资助金额:18.0 万元
- 项目类别:面上项目
中枢神经生长调节的细胞和分子基础
- 批准号:39930090
- 批准年份:1999
- 资助金额:100.0 万元
- 项目类别:重点项目
相似海外基金
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:1046501010465010
- 财政年份:2023
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:1059604710596047
- 财政年份:2023
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:1063836410638364
- 财政年份:2023
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
A suite of conditional mouse models for secretome labeling
一套用于分泌蛋白组标记的条件小鼠模型
- 批准号:1064078410640784
- 财政年份:2023
- 资助金额:$ 15.47万$ 15.47万
- 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:1064326910643269
- 财政年份:2023
- 资助金额:$ 15.47万$ 15.47万
- 项目类别: